Are generic drug prices too low?

Perhaps the answer is yes, if we want to have a more resilient supply chain. At least that is the argument from a commentary by Mattingly and Conti (2022): Several medications that patients need have been in short supply before and during the COVID-19 pandemic, including low-priced, off-patent generic drugs. The White House recently released…

Veterans health care news

As I do every year on Memorial Day, I like to review recent news articles surrounding health care for veterans. Corruption: On the negative side, we have news of a former VA employee stealing HIV medication. A former pharmacy procurement technician was sentenced today to 57 months in prison for stealing prescription HIV medications from…

ICER’s updated process for determining unsupported price increases (UPI)

Last month, ICER updated their protocol for identifying drugs that have unsupported price increases (UPI). Not only is ICER examining rising drug prices, but California and Vermont now have laws tracking substantial drug price increases, requiring drug manufacturers to submit information that might justify increases above a certain threshold. ICER says that the UPI reports…

Links

REITs own 3% of all hospitals and 12% of all skilled nursing facilities. DCE methods: Separating attribute non-attendance from taste heterogeneity. Causal Directed Acyclic Graphs (DAG). Remote work and home prices. Legislation to combat prior authorization delays.

Gene therapies and the ISPOR value flower

What considerations beyond quality adjusted life years and cost should be considered when evaluating gene therapies? A panel from ISPOR provided just such a discussion. As summarized an ISPOR’s Value and Outcomes Spotlight article titled “Can Pharmaceutical Pricing Move Beyond Cost QALY for Value Consideration?“, Michael F. Drummond pointed out that: …there are other values…